Espumisan Baby, 100 mg/ml 30 ml

Pharmacotherapeutic group: veterinary medicine

ATX code: A03AX13

Pharmacological properties

Pharmacodynamics.

The active ingredient simethicone, reduces the amount of gas in the gastrointestinal tract (GIT): Has surface-active properties and the ability to reduce the surface tension at the liquid/gas interface, which promotes the coalescence of gas bubbles and the destruction of foam in the intestine, whereby the released gas is absorbed or excreted naturally under the influence of intestinal peristalsis. The use of simmentikon in preparation for diagnostic examinations of the abdominal cavity is aimed at preventing image defects caused by gas bubbles.

Pharmacokinetics

Simethicone is chemically inert and after oral administration is not absorbed from the gastrointestinal tract and acts only in its lumen. It does not interact with microorganisms and enzymes and does not affect digestive processes. It is excreted by the intestine unchanged.

Indications

symptoms of intestinal colic in infants;
symptoms of excessive formation and accumulation of gases in the gastrointestinal tract (including flatulence, increased gas formation in the postoperative period);
symptoms of excessive gas formation caused by functional dyspepsia;
preparation for diagnostic studies of the abdominal and pelvic organs (ultrasound, radiography, esophagogastroduodenoscopy, etc.), including as an additive to suspensions of contrast agents to obtain images using the double contrast method;
acute poisoning with detergents containing foaming agents (tensides) as defoamers.

Pharmacological effect

Pharmacotherapeutic group: carminative

ATX code: A03AX13

Pharmacological properties

Pharmacodynamics

The active ingredient simethicone reduces the amount of gases in the gastrointestinal tract (GIT): it has surfactant properties and the ability to reduce surface tension at the liquid/gas interface, which promotes the fusion of gas bubbles and the destruction of foam in the intestines, as a result of which the released gas is absorbed or excreted naturally under the influence of intestinal peristalsis. The use of simenticon in preparation for diagnostic studies of the abdominal organs is aimed at preventing the occurrence of image defects caused by gas bubbles.

Pharmacokinetics

Simethicone is chemically inert, after oral administration it is not absorbed from the gastrointestinal tract and acts only in its lumen. Does not interact with microorganisms and enzymes and does not affect digestion processes. It is excreted unchanged by the intestines.

Special instructions

If gastrointestinal symptoms persist for a long time (more than 14 days of therapy) or new symptoms occur, a medical examination is necessary.

Espumisan® baby contains sorbitol (sorbitol), therefore its use in patients with hereditary fructose intolerance is contraindicated.
Information for patients with diabetes: 1 ml of emulsion (25 drops) contains 199.17 mg of sorbitol, which corresponds to 0.017 bread units (XU).

The effect of the drug on the ability to drive vehicles and machinery

The use of the drug does not affect the ability to perform potentially hazardous activities that require increased concentration and speed of psychomotor reactions (driving vehicles, working with moving mechanisms, working as a dispatcher, operator).

Active ingredient

Simethicone

Composition

1 ml (25 drops) of the drug contains:

Active ingredient: simethicone – 100.00 mg

Excipients: macrogol stearate 40, glyceryl monostearate 40-55, carbomer, banana flavor, acesulfame potassium, liquid sorbitol (non-crystallizing), sodium chloride, sodium citrate, sodium hydroxide, sorbic acid, purified water.

*Simethicone consists of dimethicone (polydimethylsiloxane (PDMS)) and silica in a ratio of 96:4

Pregnancy

Since simethicone is not absorbed from the gastrointestinal tract, no adverse effects are expected when using the drug during pregnancy and breastfeeding. However, as with the use of any other medicines, the drug should be prescribed with caution during pregnancy and breastfeeding.

Contraindications

Hypersensitivity to the components of the drug, intestinal obstruction, hereditary fructose intolerance.

Side Effects

No side effects were observed when using Espumisan® baby.
It is possible to develop allergic reactions to the components of the drug.
If you experience side effects listed in the instructions or they get worse, or you notice any side effects not listed in the instructions, tell your doctor.

Interaction

Clinically significant interactions of simethicone with other drugs have not been established.

Overdose

There are no known cases of overdose.

Storage conditions

Store at a temperature not exceeding 25 °C. Do not freeze!
Keep out of the reach of children!

Shelf life

3 years.

Do not use after expiration date.

After opening the bottle for the first time, use the drug within 6 months.

Organization receiving complaints from consumers:

LLC “Berlin-Chemie/A. Menarini”, Russia

123112, Moscow, Presnenskaya embankment, building 10, Business Center “Tower on the Embankment”, Block B, tel. (495) 785-01-00, fax (495) 785-01-01.

Manufacturer

Berlin-Chemie AG, Germany